Tag: KarMMa-3

Home / KarMMa-3

Categories

CAR T-cell treatment provides significant remission rates in clinical trials

Feb 2023: In a Phase III study, a CAR T-cell therapy more than tripled progression-free survival compared with standard care for triple-class exposed multiple myeloma. Abecma (idecabtagene vicleuc...
karmma-3

Scan the code